This Clinical Chemistry and Laboratory Medicine review examines a central challenge in precision medicine: whether medical ...

BUFFALO, N.Y. ­— Imagine if diagnosis and treatment for devastating conditions such as Alzheimer’s disease could be developed quickly by extensive profiling of protein signatures in human tissues.

Accurately distinguishing renal cell carcinoma (RCC) from normal kidney tissue is critical for identifying positive surgical margins (PSMs) during partial and radical nephrectomy, which remains the ...

In a recent study posted to the Preprints with The Lancet SSRN* server, a team of researchers in China developed a machine learning-based diagnostic tool to detect tuberculosis and drug-resistant ...

A new prototype could supercharge mass spectrometry by analyzing thousands of molecules at once instead of one by one. The breakthrough boosts sensitivity enough to reveal rare, hidden ...

The detection and study of isotopes, atoms of the same element that have different numbers of neutrons, could expand the ...

In her lab at the Jackson Laboratory (JAX), Kristen O’Connell wants to know what goes awry in the brains of people with Alzheimer’s disease. One step toward answering this question is comparing the ...

Mass spectrometry is the new genomics, and Tucson is the place to be for the emerging market. At least that’s what Nina Ossanna, vice president and co-founder of Pharos Diagnostics, thinks. Ossanna is ...

Assistant Professor at the University of Amsterdam, where he leads the Environmental Modeling & Computational Mass Spectrometry (EMCMS) group. He is also an Honorary Associate Professor at the ...

Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers Accurately distinguishing renal cell carcinoma (RCC) from normal kidney ...